01/31/2025
3:33 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:48 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:53 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:43 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:15 PM | Nurix Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:33 PM | ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
4:28 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:20 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:54 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:34 AM | FMR LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/02/2024
5:00 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
11:48 AM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
4:37 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
4:48 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:50 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:41 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:36 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
3:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:01 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:41 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:47 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2024
3:48 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:16 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
6:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:32 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:28 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
5:23 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:41 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:24 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:25 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon’s Chosen Ones (Ad) Millions of Federal employees just got put on notice...
In a single sweeping move, President Trump just offered to pay eight months' salary to any Federal worker who voluntarily quits.
But according to one Boston-based think tank, who has consulted with the Pentagon, US Army, Harvard and who's work has been followed by many of the world's biggest banks... It's likely just the start of a MUCH more radical move. |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:31 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:06 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:45 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
07/01/2024
5:35 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
2:23 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:39 PM | Nurix Therapeutics (Issuer)
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
06/05/2024
5:01 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
5:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
6:06 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:25 PM | Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:26 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:26 PM | Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:01 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:19 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:10 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/12/2024
4:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:06 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/10/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
6:06 AM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
12:17 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024
6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:20 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:22 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:51 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
6:22 AM | Nurix Therapeutics (Issuer)
SANDS ARTHUR T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:51 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:00 AM | Nurix Therapeutics (Subject)
SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024
12:47 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
12:56 PM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
